Literature DB >> 29358128

Transferrin and tocopheryl-polyethylene glycol-succinate dual ligands decorated, cisplatin loaded nano-sized system for the treatment of lung cancer.

Guobin Xu1, Ying Chen1, Renfei Shan2, Xiandan Wu3, Lijun Chen4.   

Abstract

Nanocarriers decorated with different ligands were used to achieve lung cancer treatment. Surface decoration of nanoparticulate system will assist in targeting the drug to specific tumor cells and tissues. The aim of this research was to develop a dual ligands decorated nanocarriers (NCs), which could increase the cell uptake and anti-tumor efficiency. Two different ligands: Transferrin (Tf) and D-α-tocopheryl polyethylene glycol succinate (TPGS) containing ligands were synthesized. Dual ligands decorated nanocarriers (DL-NCs) was constructed. The in vitro cytotoxicity, in vivo biodistribution, and in vivo antitumor efficacy of the DL-NCs were evaluated. DL-NCs can efficiently deliver cisplatin (CDDP) into lung cancer cells in vitro and reduced xenograft tumor size in vivo. The encapsulation of CDDP in the DL-NCs significantly improved the cytotoxicity and antitumor efficacy. DL-NCs held great potential for achieving an optimal therapeutic effect in the treatment of lung cancer.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cisplatin; Dual ligands decorated; Lung cancer; Nanocarriers; Tocopheryl-polyethylene glycol-succinate; Transferrin

Mesh:

Substances:

Year:  2018        PMID: 29358128     DOI: 10.1016/j.biopha.2018.01.062

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity.

Authors:  Zhaoqiang Dong; Yuzhen Wang; Jing Guo; Chuan Tian; Wengu Pan; Hongwei Wang; Jieke Yan
Journal:  Drug Des Devel Ther       Date:  2022-08-11       Impact factor: 4.319

2.  Transferrin-Decorated Protein-Lipid Hybrid Nanoparticle Efficiently Delivers Cisplatin and Docetaxel for Targeted Lung Cancer Treatment.

Authors:  Kaiping Mao; Weina Zhang; Lan Yu; Yi Yu; Haixia Liu; Xiaotao Zhang
Journal:  Drug Des Devel Ther       Date:  2021-08-10       Impact factor: 4.162

3.  Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles.

Authors:  Yun Bian; Dong Guo
Journal:  Drug Des Devel Ther       Date:  2020-02-18       Impact factor: 4.162

Review 4.  Nanocomposites as biomolecules delivery agents in nanomedicine.

Authors:  Magdalena Bamburowicz-Klimkowska; Magdalena Poplawska; Ireneusz P Grudzinski
Journal:  J Nanobiotechnology       Date:  2019-04-03       Impact factor: 9.429

Review 5.  Chemopreventive Potential of Dietary Nanonutraceuticals for Prostate Cancer: An Extensive Review.

Authors:  Hitesh Chopra; Shabana Bibi; Rajat Goyal; Rupesh K Gautam; Rashmi Trivedi; Tarun Kumar Upadhyay; Mohd Hasan Mujahid; Mohammad Ajmal Shah; Muhammad Haris; Kartik Bhairu Khot; Gopika Gopan; Inderbir Singh; Jin Kyu Kim; Jobin Jose; Mohamed M Abdel-Daim; Fahad A Alhumaydhi; Talha Bin Emran; Bonglee Kim
Journal:  Front Oncol       Date:  2022-07-12       Impact factor: 5.738

6.  Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer.

Authors:  Zhiyu Wang; Aimin Zang; Yaning Wei; Lin An; Dan Hong; Yan Shi; Jingnan Zhang; Shenyong Su; Guotao Fang
Journal:  Drug Des Devel Ther       Date:  2020-03-12       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.